96898 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Immunogenic fragment peptide of EN2 protein or antibody composition specifically recognizing same
#1502H3.3 CTL peptides and uses thereof
#1503FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE
#1504Systems and methods for control of gene expression
#1505Htt repressors and uses thereof
#1506Transdermal peptide with nuclear localization ability and use thereof
#1507Heat shock protein-binding peptide compositions and methods of use thereof
#1508Peptides and combination of peptides for use in immunotherapy against various cancers
#1509Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#1510Compositions and methods for identifying RNA binding polypeptide targets
#1511Peptides for angiogenic therapy
#1512Artificial ribosomes for fully programmable synthesis of nonribosomal peptides
#1513Fusion molecules
#1514Methods and compositions for reducing metastases
#1515Botulinum neurotoxins with modified light chain specificity and methods for producing same
#1516METHODS AND COMPOSITIONS FOR TREATMENT OF IONIZING RADIATION RESISTANT TUMORS
#1517Genetic and pharmacological transcriptional upregulation of the repressed FXN gene as a therapeutic strategy for Friedreich ataxia
#1518CELLS WITH IMPROVED INWARD RECTIFIER CURRENT
#1519REGULATORY T CELL POPULATIONS
#1520EFFECTIVE GENERATION OF TUMOR-TARGETED T CELLS DERIVED FROM PLURIPOTENT STEM CELLS
#1521COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#1522Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species
#1523Method of treating breast cancer
#1524NAF-1 derived peptides and uses thereof
#1525ULTRASOUND-SENSING PROTEINS AND METHOD FOR STIMULATING CELLS BY ULTRASOUND
#1526Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#1527Therapeutic compositions
#1528Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer
#1529Methods for treatment of erectile dysfunction with sonic hedgehog compounds
#1530CALRETICULIN AND FUSION PROTEINS
#1531COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING FIBROSIS, SYSTEMIC SCLEROSIS, SCLERODERMA AND GRAFT VERSUS HOST DISEASE
#1532Methods of increasing muscle mass by administration of activin type 2 receptor antibodies
#1533CENTRAL NERVOUS SYSTEM TARGETING POLYNUCLEOTIDES
#1534Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
#1535Liver-type fatty acid-binding protein standard, method for evaluating standard, method for regulating variation range of measured value caused by liver-type fatty acid-binding protein in measurement using standard, liver-type fatty acid-binding protein, DNA encoding protein, cell transformed by DNA, method of producing protein, method of drawing calibration curve for liver-type fatty acid-binding protein, and method of quantifying protein
#1536ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM
#1537Identification, selection and use of high curative potential T cell epitopes
#1538Methods and compositions for making vault particles in yeast
#1539COMPOSITIONS TARGETING THE SOLUBLE EXTRACELLULAR DOMAIN OF E-CADHERIN AND RELATED METHODS FOR CANCER THERAPY
#1540Methods and compositions for delivering interleukin-1 receptor antagonist
#1541Methods of processing ß-lactoglobulin-containing compositions with thermolysin and transglutaminase
#1542Dual inhibitory action peptidomimetic inhibitor for IL-33 and IL-1beta
#1543MODIFIED PEPTIDES AND THEIR USE FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#1544Organic solvent method for preparing membrane protein based nanosheets and membranes based on nanosheets
#1545REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
#1546Sensors and assays for ubiquitin or ubiquitin-like proteins
#1547Methods and compositions for treating hemophilia
#1548Lipocalin muteins with binding affinity for LAG-3
#1549Engineered Fc constructs
#1550Preparation of recombinant tetrameric N-acetylated alpha-synuclein
#1551AAV-MEDIATED GENE THERAPY FOR NPHP5 LCA-CILIOPATHY
#1552Inhibiting the onset of gout
#1553Method to overcome DNA chemical modifications sensitivity of engineered TALE DNA binding domains
#1554IL-31 ANTIBODY COMPOSITIONS
#1555Proteins specific for calcitonin gene-related peptide
#1556Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same
#1557Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
#1558Modification and compositions of human secretoglobin proteins
#1559SYSTEMS, METHODS AND COMPOSITIONS FOR OPTICAL STIMULATION OF TARGET CELLS
#1560Intrathecal delivery of recombinant adeno-associated virus 9
#1561IMMUNIZING PEPTIDE, METHOD FOR PRODUCING IMMUNIZING PEPTIDE, PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE CONTAINING SAME, AND METHOD FOR TREATING IMMUNE DISEASE
#1562Reagents and methods for detecting protein lysine 3-hydroxybutyrylation
#1563CONTROL OF PROTEIN TO PROTEIN INTERACTIONS OF ACID DECARBOXYLASE
#1564GENERATION OF BRAIN AND SPINAL CORD NEURONS, CARDIAC MYOCYTES, RENAL NEPHRONS AND HEPATOCYTES USING REG PEPTIDES, PEPTIDOMIMETICS, SMALL MOLECULES AND STIMULATORY ANTIBODIES TO REG RECEPTOR
#1565Methods for enhancing the pluripotency of stem cells
#1566Optimized Synthetic Consensus Immunogenic Compositions Targeting Fibroblast Activation Protein
#1567Microorganism for delivering drug for treatment of gastrointestinal disease, which expresses and secretes P8 protein, and pharmaceutical composition for preventing or treating gastrointestinal disease, which includes the same
#1568Non-meiotic allele introgression
#1569CAR expression vector and CAR-expressing T cells
#1570COMPOSITIONS AND METHODS RELATED TO K180 DIMETHYLATED H1.0 PROTEIN
#1571Immunotherapy against neuronal and brain tumors
#1572ERYTHROID-SPECIFIC PROMOTER AND METHOD OF USE THEREOF
#1573Modified polynucleotides for the production of secreted proteins
#1574A Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same
#1575Peptide directed protein knockdown
#1576Scalable production of genetically engineered nanofibrous macroscopic materials via filtration
#1577In vivo production of proteins
#1578Stabilized influenza hemagglutinin stem region trimers and uses thereof
#1579Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1580Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1581NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE
#1582Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
#1583Fusion protein Slit2D2(C386S)-HSA and use thereof in treatment of fibrotic diseases
#1584CRYPTIC POLYPEPTIDES AND USES THEREOF
#1585Recombinant protein-based method for the delivery of silencer RNA to target the brain
#1586Methods for treating bone loss using sclerostin peptides
#1587METHODS FOR INCREASING THE FREQUENCY OF GENE TARGETING BY CHROMATIN MODIFICATION
#1588Peptides and combination of peptides for use in immunotherapy against various tumors
#1589Nucleic Acids for Treatment of Peanut Allergies
#1590Methods for treatment of cancer by targeting SIRT5
#1591Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
#1592Internalizing moieties
#1593GDF15 fusion proteins and uses thereof
#1594Separation of metal ions by liquid-liquid extraction
#1595Methods for treatment of cancer comprising TIGIT-binding agents
#1596PROGRAMMABLE IMMUNOCYTE RECEPTOR COMPLEX SYSTEM
#1597BETA-CATENIN BARCODED PEPTIDES
#1598Methods for enhancing lifespan and/or treating cellular proliferative disorders by transplantation
#1599Application of artificially expressed HSP27 protein in detecting a residue of a β2-adrenergic receptor agonist-based drug
#1600GENE FOR IDENTIFYING INDIVIDUALS WITH FAMILIAL DYSAUTONOMIA
#1601Method of purification of recombinant osteopontin from micro algae
#1602Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#1603Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#1604SH2 DOMAIN VARIANTS
#1605Production cell line enhancers
#1606Intrathecal delivery of recombinant adeno-associated virus 9
#1607Peptides and combination of peptides for use in immunotherapy against various cancers
#1608Compounds and Methods Useful for Detection and Treatment of Cancer
#1609Modulation of intestinal epithelial cell differentiation, maintenance and/or function through T cell action
#1610Compositions, methods, and therapeutic uses related to fusogenic protein minion
#1611Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides
#1612Recombinant binding proteins and their use
#1613Intrathecal delivery of recombinant adeno-associated virus 9
#1614Peptides and combination of peptides for use in immunotherapy against various cancers
#1615Antibodies specific for LOX1 and use in treatment of cardiovascular disorders
#1616Compositions and methods for diagnosing and/or treating kidney injury
#1617Preparation method of adiposomes, and use thereof
#1618ABCG2 monoclonal antibody and uses thereof
#1619Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS
#1620NOVEL a4ß7 PEPTIDE DIMER ANTAGONISTS
#1621SYNTHETIC TRANSCRIPTIONAL REGULATOR COMPOSITIONS AND METHODS
#1622MITOCHONDRIAL PROTEINS CONSTRUCTS AND USES THEREOF
#1623Serologic assay of liver fibrosis
#1624Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia
#1625Synthetic peptide, relative artificial antigen, relative anti-EHD2 antibody and preparation method thereof and use thereof
#1626Protein secretory production method
#1627Secretory production method for protein
#1628Structure-based peptide inhibitors of alpha-synuclein aggregation
#1629Channeled fibers in separation of biologically active nanoparticles
#1630MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
#1631Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#1632Tear lipocalin muteins binding IL-4 r alpha
#1633Compositions and methods related to the methylation of histone H1.0 protein
#1634Human Anti-Tau Antibodies
#1635Methods and compositions relating to covalently circularized nanodiscs
#1636Anti-PACAP antibodies and uses thereof
#1637KIDNEY DISEASE TARGETS AND USES THEREOF
#1638Antimicrobial peptides based on CMAP27
#1639Inducible caspases and methods for use
#1640Compositions and methods for vascular protection against reperfusion injury after myocardial ischemia
#1641METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS
#1642Method for preparing a complete protein and uses thereof
#1643COMPOSITIONS FOR THE TREATMENT OF DISEASE
#1644BIO-MIMETIC FORMULATION
#1645Nonviral minicircle vector carrying SOX gene and construction method therefor
#1646Cellular vamp cleavage assay
#1647Chimeric poxvirus compositions and uses thereof
#1648PAC1 antibodies and uses thereof
#1649Triple glucagon/GLP-1/GIP receptor agonist
#1650Methods for enhancing immune responsiveness in an individual toward a target cancer cell population comprising apoptotic cells
#1651Compositions and methods for brown fat induction and activity using FNDC5
#1652Nanocage and use thereof
#1653Compositions, methods and uses comprising teneurin C-terminal associated peptide -1 (TCAP-1) for enhancing muscle performance
#1654Development and use of fluorescent probes of unbound bilirubin
#1655RNA virus vectors carrying DAI and RIPK3
#1656Method of inhibiting the enzymatic activity of vascular endothelial lipase with a monoclonal antibody
#1657Nucleic acids for single-domain antibodies with thermal stability under cytoplasmic expression
#1658Single-domain antibody fusion proteins with the acid tail of alpha-synuclein
#1659Modified proteins and methods of use thereof
#1660Compositions and methods for selectively sequestering metal ions
#1661Increasing ATOH1 life to drive sensorineural hair cell differentiation
#1662Fusion proteins and methods thereof
#1663Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
#1664PASSIVE VACCINE FOR ELIMINATION OF SENESCENT CELLS
#1665BLOCKADE OF ALPHAFETOPROTEIN (AFP) INTERACTIONS WITH BETA2-MICROGLOBULIN ASSOCIATED MOLECULES
#1666NNIF and nNIF-related peptides and related methods
#1667ATF5 peptide variants and uses thereof
#1668Antibodies to TTR and methods of use
#1669Methods and compositions for diagnosing brain injury or neurodegeneration
#1670Embryonic cell-based therapeutic candidate screening systems, models for Huntington's Disease and uses thereof
#1671Methods and compositions for screening and treating developmental disorders
#1672EFFICIENT NON-MEIOTIC ALLELE INTROGRESSION IN LIVESTOCK
#1673UTRs increasing the translation efficiency of RNA molecules
#1674RAPID AND SIMPLIFIED DEVELOPING ANTIBODIES AND FABs OR OTHER MOLECULES CONSISTING OF AMINO ACIDS RECOGNIZING NATURAL ANTIGENS OR NON-NATURAL MOLECULAR TARGETS USING SPECIAL BLOCKING AGENT
#1675MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications
#1676Specific active site inhibitors of enzymes or substrate binding partners and methods of producing same
#1677Use of regulatory T cell-specific surface protein LRIG-1
#1678NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#1679Complex-specific standardization of immunological methods for the quantification of S100A12
#1680SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES
#1681Scorpion toxin fusion protein with enhanced skin cell proliferation effect and cosmetic composition for anti-wrinkle, enhancing skin elasticity and anti-aging comprising the same as an effective ingredient
#1682Chelating platform for delivery of radionuclides
#1683COMPOSITIONS FOR SELECTIVE HUMORAL RESPONSES AND METHODS OF USE THEREOF
#1684Regulatory T cell epitopes, compositions and uses thereof
#1685Regulatory T cell epitopes, compositions and uses thereof
#1686Fusion protein comprising apelin and an anti-APLNR antibody
#1687Cancer vaccines targeting LEMD1 and uses thereof
#1688Polynucleotides encoding citrin for the treatment of Citrullinemia type 2
#1689Method and reagent for detecting ovarian clear cell adenocarcinoma
#1690Human serum albumin binding compounds and fusion proteins thereof
#1691Method of protecting tissue from damage by administering a bi-specific therapeutic protein comprising insulin-like growth factor 1 (IGF-1) and Annexin A5
#1692Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2
#1693Compositions and methods for enhancing visual function
#1694Compositions containing HC-HA/PTX3 complexes and methods of use thereof
#1695Method for producing gelatin formed body and gelatin formed body
#1696Polypeptides binding to human complement C5
#1697Peptides and compositions for treatment of joint damage
#1698Materials and methods for treatment of friedreich ataxia and other related disorders
#1699Preparation of flagellin vaccine adjuvant-based vaccine to induce production of antibody recognizing conformation of antigens, and application thereof
#1700Methods to Treat Diseases with Protein, Peptide and Antigen Modification
#1701Oncolytic expression vector comprising a nucleic acid comprising a nucleotide sequence encoding GADD34
#1702MG53 mutants, methods of making the same, and uses thereof
#1703Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist
#1704Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases
#1705Dual-AAV vector-based systems and methods for delivering oversized genes to mammalian cells
#1706Intrathecal delivery of recombinant adeno-associated virus 9
#1707Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereof
#1708Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide
#1709Core domain of annexins and uses thereof in antigen delivery and vaccination
#1710PLIF MULTIMERIC PEPTIDES AND USES THEREOF
#1711Modification of RNA-related enzymes for enhanced production
#1712INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9
#1713Intrathecal delivery of recombinant Adeno-associated virus 9
#1714Methods for treating heart failure using beta-ARKnt peptide
#1715Composition comprising PCSK9 peptide conjugated to a Qbeta carrier and methods of using the same
#1716Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage
#1717Polypeptide nano-bubbles and preparation method and application thereof
#1718Method using slit-robo system to treat sarcopenia
#1719Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
#1720Engineered FHA domains
#1721Multivalent heteromultimer scaffold design and constructs
#1722Methods and compositions for reducing infectivity of virus particles comprising an ERGIC-53 polypeptide
#1723Engineered PD-1 variants
#1724Method for producing TLR5 agonist protein
#1725Expression of neuropeptides
#1726Truncated Constructs Related To RIPK3
#1727NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#1728Peptides and combination of peptides for use in immunotherapy against various tumors
#1729Control system and method for tapered structure construction
#1730NOVEL HUMAN ULIP/CRMP PROTEIN AND USE THEREOF IN DIAGNOSIS AND TREATMENT OF CANCERS AND PARANEOPLASTIC NEUROLOGICAL SYNDROMES
#1731COMPOSITIONS AND METHODS FOR OLIGODENDROCYTE DEVELOPMENT
#1732Methods of treating mitochondrial disorders
#1733Heterocyclic compound
#1734MODULAR NANODEVICES FOR SMART ADAPTABLE VACCINES
#1735GJA1 isoforms protect against metabolic stress
#1736Compositions comprising secreted extracellular vesicles of cells expressing NFATC4 useful for the treatment of cancer
#1737Cornulin (CRNN) variants and uses thereof
#1738COMPOSITIONS AND METHODS FOR THE DETECTION DIAGNOSIS AND THERAPY OF HEMATOLOGICAL MALIGNANCIES
#1739Decoy peptides inhibiting protein phosphatase 1-medicated dephosphorylation of phospholamban
#1740HIV peptide vaults and methods of making and using thereof
#1741Compositions and their use for controlling the nervous system in vivo
#1742NOVEL CANCER ANTIGEN EEF2
#1743Recombinant intravenous immunoglobulin (rIVIG) compositions and methods for their production and use
#1744Efficient non-meiotic allele introgression in livestock
#1745ANTIBODY AGAINST PEPTIDE ENCODED BY EXON-21 OF PERIOSTIN AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATION-ASSOCIATED DISEASES CONTAINING THE SAME
#1746Over-expression of AZF1 improves the rate of anaerobic xylose fermentation in engineered yeast strains
#1747Wnt/sFRP complexes, Wnt-containing compositions, Wnt-expressing cells, and methods of making, purifying, and using same
#1748Engineered polypeptides for antigen delivery
#1749LIPOCALIN FUSION PARTNERS
#1750COMPOSITIONS AND METHODS FOR ENHANCED GENE EXPRESSION AND VIRAL REPLICATION
#1751INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9
#1752NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 161P2F10B USEFUL IN TREATMENT AND DETECTION OF CANCER
#1753Prion protein-dendrimer conjugates for use in treatment of alzheimer disease
#1754FUNCTIONAL LIGANDS TO PEPTIDES
#1755Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#1756Polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders
#1757POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY AND METHODS OF USING SAME
#1758Diagnostic for sjorgen's syndrome based on a biomarker
#1759Secretory protein
#1760Peptide modulators of specific calcineurin protein-protein interactions
#1761Strigolactone formulations and uses thereof
#1762Use of endostatin peptides for the treatment of fibrosis
#1763Peptides with anti-cancer activity
#1764Methods and compositions to increase the rate of ligation reactions catalyzed by a sortase
#1765C3-carbon linked glutarimide degronimers for target protein degradation
#1766Immunotherapy against neuronal and brain tumors
#1767Methods of identifying a polypeptide target for degradation by a modulator of CRBN
#1768Promoter
#1769Method for diagnosing alzheimer's disease using signal peptide as indicator
#1770Opsin polypeptides and methods of use thereof
#1771Nanospheres of SEC14-like proteins and cognate ligands
#1772Activated polyoxazolines and conjugates and compositions comprising the same
#1773NEOANTIGEN COMPOSITIONS AND METHODS OF USING THE SAME IN IMMUNOONCOTHERAPY
#1774Methods and compositions for preventing or treating cancer
#1775Fc γ RIII binding fibronectin type III domains, their conjugates and multispecific molecules comprising them
#1776Compositions and methods for treatment of disorders related to CEP290
#1777Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
#1778Compositions and methods useful in treating Stargardt's disease and other ocular disorders
#1779KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME
#1780USE OF LINGO-4 ANTAGONISTS IN THE TREATMENT OF CONDITIONS INVOLVING DEMYELINATION
#1781DELIVERY OF CENTRAL NERVOUS SYSTEM TARGETING POLYNUCLEOTIDES
#1782METHODS TO PRODUCE ROD-DERIVED CONE VIABILITY FACTOR (RDCVF)
#1783Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#1784Methods for the diagnosis and treatment of gastrointestinal stromal tumors
#1785Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR
#1786CARGOMERS
#1787FUSION PROTEINS AND METHODS FOR IDENTIFYING BROMODOMAIN INHIBITING COMPOUNDS
#1788Cancer vaccines and methods of treatment using the same
#1789Peptides derived from actin-like protein 8 (ACTL8)
#1790Methods of treatment using hemopexin compositions
#1791Adenovirus-associated viral vectors for expressing variants of tetratricopeptide repeat (TPR)-containing Rab8b interacting (TRIP8b) protein in neurons and uses thereof for treating major depressive disorder (MDD)
#1792RECURRENT FUSION GENES IN HUMAN CANCERS
#1793VEGF antagonist formulations suitable for intravitreal administration
#1794BIGLYCAN VARIANT POLYPEPTIDES AND METHODS OF USE
#1795Muteins of human tear lipocalin capable of binding lymphocyte-activation gene 3 (LAG-3) and methods of use thereof
#1796Colostrum solid extraction process
#1797DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9
#1798Regulatory T cell epitopes, compositions and uses thereof
#1799Regulatory T cell epitopes, compositions and uses thereof
#1800Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages